Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Diogenes Theiss

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|October 4, 2007
Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cellsStefan Brunner, Hans Diogenes Theiss, Alfons Murr, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 21, 2018
Hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in KUM ABSORB registryMoritz Baquet, David Grundmann, Wolfgang Schmidt, et al.
International Journal of Cardiology|May 1, 2016
Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction - Long-term results of the SITAGRAMI trialLisa Gross, Hans Diogenes Theiss, Ulrich Grabmaier, et al.
European Heart Journal. Cardiovascular Imaging|October 1, 2015
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarctionLisa Gross, Lisa Paintmayer, Sebastian Lehner, et al.
International Journal of Cardiology|December 29, 2015
Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial)Christoph Brenner, Christine Adrion, Ulrich Grabmaier, et al.
Cell Stem Cell|April 4, 2009
Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarctionMarc-Michael Zaruba, Hans Diogenes Theiss, Markus Vallaster, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Physiology. Endocrinology and Metabolism|October 4, 2007
Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cellsStefan Brunner, Hans Diogenes Theiss, Alfons Murr, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 21, 2018
Hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in KUM ABSORB registryMoritz Baquet, David Grundmann, Wolfgang Schmidt, et al.
International Journal of Cardiology|May 1, 2016
Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction - Long-term results of the SITAGRAMI trialLisa Gross, Hans Diogenes Theiss, Ulrich Grabmaier, et al.
European Heart Journal. Cardiovascular Imaging|October 1, 2015
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarctionLisa Gross, Lisa Paintmayer, Sebastian Lehner, et al.
International Journal of Cardiology|December 29, 2015
Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial)Christoph Brenner, Christine Adrion, Ulrich Grabmaier, et al.
Cell Stem Cell|April 4, 2009
Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarctionMarc-Michael Zaruba, Hans Diogenes Theiss, Markus Vallaster, et al.
Pageof 1